May 25 | 2023
Kommuniké från årsstämma i 2cureX AB
Read more
May 11 | 2023
Positive IndiTreat® trial results published in highly recognized scientific journal.
Read more
April 27 | 2023
Kallelse till årsstämma i 2cureX AB (publ)
Read more
April 27 | 2023
Notice of annual general meeting of 2cureX AB (publ)
Read more
April 25 | 2023
2cureX’s CEO Fernando Andreu purchases shares in the company
Read more
April 12 | 2023
2cureX presents preliminary Q1 2023 commercial results.
Read more
April 12 | 2023
2cureX has received a grant from the Innovation Fund Denmark to support clinical development of a novel IndiTreat® product.
Read more
April 10 | 2023
Invitation to 2cureX Q1 update and Q&A session on April 12, 2023 at 20.00 (CET)
Read more
April 6 | 2023
2cureX strengthens its IndiTreat® automation project with a prestigious grant from the German Federal Ministry of Education and Research
Read more
March 23 | 2023
2cureX announces launch of updated Specimen Collection Set
Read more
February 15 | 2023
Invitation to 2cureX webcast on Year-End Report and latest news on February 24, 2023
Read more
February 10 | 2023
Announcement from extraordinary general meeting 2cureX AB
Read more
February 10 | 2023
Kommuniké från extra bolagsstämma i 2cureX AB
Read more
January 23 | 2023
NOTICE TO ATTEND THE EXTRAORDINARY GENERAL MEETING OF 2CUREX AB (PUBL)
Read more
January 23 | 2023
KALLELSE TILL EXTRA BOLAGSSTÄMMA I 2CUREX AB (PUBL)
Read more
January 19 | 2023
2cureX announces final results regarding 2022 goals
Read more
December 20 | 2022
2cureX reaches 2022 geographic rollout goal of 20 countries
Read more
November 22 | 2022
Invitation to 2cureX webcast and conference call on November 24, 2022
Read more